Skip to content
10-K

Annual Report

ADAPTIMMUNE THERAPEUTICS PLC ADAPY

0001558370-25-003544

← back to feed
Filed
Mar 24, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 21, 2025 1.54B sh
Shares Diluted FY 2024 · Dec 31, 2024 1.51B sh
Shares Diluted FY 2024 · Dec 31, 2023 1.21B sh
Shares Diluted FY 2024 · Dec 31, 2022 967.24M sh
Capex FY 2024 · Dec 31, 2024 $886K
Capex FY 2024 · Dec 31, 2023 $4.68M
Capex FY 2024 · Dec 31, 2022 $29.5M
Operating Cash Flow FY 2024 · Dec 31, 2024 −$73.21M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$140.88M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$141.77M
Long Term Debt FY 2024 · Dec 31, 2024 $50.24M
Cash And Equivalents FY 2024 · Dec 31, 2024 $91.14M
Cash And Equivalents FY 2024 · Dec 31, 2023 $143.99M
Stockholders Equity FY 2024 · Dec 31, 2024 $11.85M
Stockholders Equity FY 2024 · Dec 31, 2023 $39.51M
Stockholders Equity FY 2024 · Dec 31, 2022 $81.88M
Stockholders Equity FY 2024 · Dec 31, 2021 $205.96M
Current Liabilities FY 2024 · Dec 31, 2024 $64.53M
Current Liabilities FY 2024 · Dec 31, 2023 $72.79M
Total Liabilities FY 2024 · Dec 31, 2024 $234.11M
Total Liabilities FY 2024 · Dec 31, 2023 $243.1M
Current Assets FY 2024 · Dec 31, 2024 $188.17M
Current Assets FY 2024 · Dec 31, 2023 $207.55M
Total Assets FY 2024 · Dec 31, 2024 $245.96M
Total Assets FY 2024 · Dec 31, 2023 $282.62M
Eps Diluted FY 2024 · Dec 31, 2024 −$0.05
Eps Diluted FY 2024 · Dec 31, 2023 −$0.09
Eps Diluted FY 2024 · Dec 31, 2022 −$0.17
Eps Basic FY 2024 · Dec 31, 2024 −$0.05
Eps Basic FY 2024 · Dec 31, 2023 −$0.09
Eps Basic FY 2024 · Dec 31, 2022 −$0.17
Sga Expense FY 2024 · Dec 31, 2024 $87.26M
Sga Expense FY 2024 · Dec 31, 2023 $73.51M
Sga Expense FY 2024 · Dec 31, 2022 $63.39M
Rd Expense FY 2024 · Dec 31, 2024 $149.06M
Rd Expense FY 2024 · Dec 31, 2023 $126.51M
Rd Expense FY 2024 · Dec 31, 2022 $127.73M
Net Income FY 2024 · Dec 31, 2024 −$70.81M
Net Income FY 2024 · Dec 31, 2023 −$113.87M
Net Income FY 2024 · Dec 31, 2022 −$165.46M
Operating Income FY 2024 · Dec 31, 2024 −$68.76M
Operating Income FY 2024 · Dec 31, 2023 −$139.74M
Operating Income FY 2024 · Dec 31, 2022 −$163.97M
Cost Of Revenue FY 2024 · Dec 31, 2024 $70K
Revenue FY 2024 · Dec 31, 2024 $178.03M
Revenue FY 2024 · Dec 31, 2023 $60.28M
Revenue FY 2024 · Dec 31, 2022 $27.15M